Wien, Austria; UCB Clinical Trial Call Center
Alprostadil in Macular Degeneration Study (AIMS)
Berlin, Germany; UCB Clinical Trial Call Center
Alprostadil in Macular Degeneration Study (AIMS)
Bochum, Germany; UCB Clinical Trial Call Center
Alprostadil in Macular Degeneration Study (AIMS)
Dortmund, Germany; UCB Clinical Trial Call Center
Alprostadil in Macular Degeneration Study (AIMS)
Karlsruhe, Germany; UCB Clinical Trial Call Center
Alprostadil in Macular Degeneration Study (AIMS)
Muenchen, Germany; UCB Clinical Trial Call Center
Alprostadil in Macular Degeneration Study (AIMS)
Muenster, Germany; UCB Clinical Trial Call Center
Alprostadil in Macular Degeneration Study (AIMS)
Siegburg, Germany; UCB Clinical Trial Call Center
Alprostadil in Macular Degeneration Study (AIMS)